Advertisement

Impact on Long-Term Mortality of Presence of Obstructive Coronary Artery Disease and Classification of Myocardial Infarction

Published:January 04, 2016DOI:https://doi.org/10.1016/j.amjmed.2015.11.035

      Abstract

      Background

      In contrast to the associated-with-thromboembolic-event type 1 myocardial infarction, type 2 myocardial infarction is caused by acute imbalance between oxygen supply and demand of myocardium. Type 2 myocardial infarction may be present in patients with or without obstructive coronary artery disease, but knowledge about patient characteristics, treatments, and outcome in relation to coronary artery status is lacking. We aimed to compare background characteristics, triggering mechanisms, treatment, and long-term prognosis in a large real-life cohort of patients with type 1 and type 2 myocardial infarction with and without obstructive coronary artery disease.

      Methods

      All 41,817 consecutive patients with type 1 and type 2 myocardial infarction registered in the Swedish myocardial infarction registry (SWEDEHEART) who underwent coronary angiography between January 1, 2011 and December 31, 2013, with the last follow-up on December 31, 2014, were studied.

      Results

      In 92.8% of 40,501 patients classified as type 1 and in 52.5% of patients classified as type 2 myocardial infarction, presence of an obstructive coronary artery disease could be shown. Within the patients with obstructive coronary artery disease, those with type 2 myocardial infarction were older, and had more comorbidities and smaller necrosis as compared with type 1 myocardial infarction. In contrast, there was almost no difference in risk profile and extent of myocardial infarction between type 1 and type 2 myocardial infarction patients with nonobstructive coronary artery stenosis. The crude long-term mortality was higher in type 2 as compared with type 1 myocardial infarction with obstructive coronary artery disease (hazard ratio [HR] 1.72; 95% confidence interval [CI], 1.45-2.03), but was lower after adjustment (HR 0.76; 95% CI, 0.61-0.94). In myocardial infarction patients with nonobstructive coronary artery stenosis, the mortality risk was similar regardless of the clinical myocardial infarction type (crude HR 1.14; 95% CI, 0.84-1.55; adjusted HR 0.82; 95% CI, 0.52-1.29).

      Conclusions

      The substantial differences in risk factors, treatment, and outcome in patients with type 1 and type 2 myocardial infarction with obstructive coronary artery disease supports the relevance of the division between type 1 and type 2 in this population. On the contrary, in patients with nonobstructive coronary artery stenosis, irrespective of the clinical type, a similar risk profile, extent of necrosis, and long-term prognosis were observed, indicating that distinction between type 1 and type 2 myocardial infarction in these patients seems to be inappropriate.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Thygesen K.
        • Alpert J.S.
        • White H.D.
        • Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
        Universal definition of myocardial infarction.
        J Am Coll Cardiol. 2007; 50: 2173-2195
        • Thygesen K.
        • Alpert J.
        • Jaffe A.
        • et al.
        • Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction
        Third universal definition of myocardial infarction.
        J Am Coll Cardiol. 2012; 60: 1581-1598
        • Nelson S.
        • Sandoval Y.
        • Smith S.
        • et al.
        Role of delta cardiac troponin I to distinguish between type I NSTEMI and type II myocardial infarction (abstr).
        J Am Coll Cardiol. 2013; 61: E234
        • Javed U.
        • Aftab W.
        • Ambrose J.A.
        • et al.
        Frequency of elevated troponin I and diagnosis of acute myocardial infarction.
        Am J Cardiol. 2009; 104: 9-13
        • Ambrose J.A.
        • Loures-Vale A.
        • Javed U.
        • et al.
        Angiographic correlates in type 1 and 2 MI by the universal definition.
        JACC Cardiovasc Imaging. 2012; 5: 463-464
        • Melberg T.
        • Burman R.
        • Dickstein K.
        The impact of the 2007 ESC–ACC–AHA– WHF Universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study.
        Int J Cardiol. 2010; 139: 228-233
        • Szymański F.M.
        • Karpiński G.
        • Płatek A.E.
        • et al.
        Clinical characteristics, aetiology and occurrence of type 2 acute myocardial infarction.
        Kardiol Pol. 2014; 72: 339-344
        • El-Haddad H.
        • Robinson E.
        • Swett K.
        • Wells G.
        Prognostic implications of type 2 myocardial infarctions.
        World J Cardiovasc Dis. 2012; 2: 237-241
        • Saaby L.
        • Poulsen T.S.
        • Hosbond S.
        • et al.
        Classification of myocardial infarction: frequency and features of type 2 myocardial infarction.
        Am J Med. 2013; 126: 789-797
        • Baron T.
        • Hambraeus K.
        • Sundström J.
        • et al.
        • TOTAL-AMI study group
        Type 2 myocardial infarction in clinical practice.
        Heart. 2015; 101: 101-106
        • Landes U.
        • Bental T.
        • Orvin K.
        • et al.
        Type 2 myocardial infarction: a descriptive analysis and comparison with type 1 myocardial infarction.
        J Cardiol. 2016; 67: 51-56
        • Saaby L.
        • Poulsen T.S.
        • Diederichsen A.C.
        • et al.
        Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort.
        Am J Med. 2014; 127: 295-302
        • Pasupathy S.
        • Air T.
        • Dreyer R.P.
        • et al.
        Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries.
        Circulation. 2015; 131: 861-870
        • Planer D.
        • Mehran R.
        • Ohman E.M.
        • et al.
        Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the acute catheterization and urgent intervention triage strategy trial.
        Circ Cardiovasc Interv. 2014; 7: 285-293
        • Niccoli G.
        • Scalone G.
        • Crea F.
        Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management.
        Eur Heart J. 2015; 36: 475-481
        • Tornvall P.
        • Gerbaud E.
        • Behaghel A.
        • et al.
        Myocarditis or “true” infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: a meta-analysis of individual patient data.
        Atherosclerosis. 2015; 241: 87-91
        • Collste O.
        • Sörensson P.
        • Frick M.
        • et al.
        Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study.
        J Intern Med. 2013; 273: 189-196
        • Mahmoudi M.
        • Harden S.
        • Abid N.
        • et al.
        Troponin-positive chest pain with unobstructed coronary arteries: definitive differential diagnosis using cardiac MRI.
        Br J Radiol. 2012; 85: e461-e466
        • Gehrie E.R.
        • Reynolds H.R.
        • Chen A.Y.
        • et al.
        Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
        Am Heart J. 2009; 158: 688-694
        • Aldous S.
        • Elliott J.
        • McClean D.
        • et al.
        Outcomes in patients presenting with symptoms suggestive of acute coronary syndrome with elevated cardiac troponin but non-obstructive coronary disease on angiography.
        Heart Lung Circ. 2015; 24: 869-878
        • Jernberg T.
        • Attebring M.F.
        • Hambraeus K.
        • et al.
        The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART).
        Heart. 2010; 96: 1617-1621
        • Harnek J.
        • Nilsson J.
        • Friberg O.
        • et al.
        The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART).
        Scand Cardiovasc J. 2013; 47: 1-10
        • Stein G.Y.
        • Herscovici G.
        • Korenfeld R.
        • et al.
        Type-II myocardial infarction–patient characteristics, management and outcomes.
        PLoS One. 2014; 9: e84285
        • Bugiardini R.
        • Manfrini O.
        • De Ferrari G.M.
        Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography.
        Arch Intern Med. 2006; 166: 1391-1395
        • Smith S.W.
        • Pearce L.A.
        • Murakami M.M.
        • Apple F.S.
        Diagnosis of type I versus type II myocardial infarction in emergency department patients with ischemic symptoms (abstr).
        Ann Emerg Med. 2011; 58: S211-S212
        • Hanson I.
        • Kahn J.
        • Dixon S.
        • Goldstein J.
        Angiographic and clinical characteristics of type 1 versus type 2 perioperative myocardial infarction.
        Catheter Cardiovasc Interv. 2013; 82: 622-628
        • Sandoval Y.
        • Smith S.W.
        • Schulz K.M.
        • et al.
        Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.
        Clin Chem. 2015; 61: 657-663